Method And Device For Determination Of Efficacy Of Cardiac Resynchronization Pacing Utilizing Simultaneous RV And LV Electroanotomic Cardiac Phase Motion Mapping

• US 20110160792A1
• Filed: 12/21/2010
• Published: 06/30/2011
• Est. Priority Date: 12/23/2009
• Status: Abandoned Application

• Current Assignee: Robert S. Fishel
• Original Assignee: Robert S. Fishel
• Inventors: Fishel, Robert S.
• Application Number:
  US12/974,831
• Publication Number:
  US 20110160792A1
• Time in Patent Office: Days
• US Class Current: 607/27
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/36578 controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence

Abstract

The current invention describes a method and system to measure and validate the efficacy of cardiac resynchronization therapy pacing using electroanatomical position and motion sensing during the various phases of the cardiac cycle. In this method, electroanatomical position and motion sensors are utilized with sensing from the tip of both right ventricular pacing lead and left ventricular pacing lead. An operator can therefore obtain data not currently available to an implanter with current technology. This data includes the physical distance between both leads and the relative motion of both leads during cardiac resynchronization therapy biventricular pacing. If good lead positioning for both the right ventricular lead and left ventricular lead has been obtained, then the operator will be able to demonstrate good synchronization of the cardiac cycle.

Claims